| Product Code: ETC9484853 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sudan Basal Insulin (Long Acting Insulin) Market Overview |
3.1 Sudan Country Macro Economic Indicators |
3.2 Sudan Basal Insulin (Long Acting Insulin) Market Revenues & Volume, 2021 & 2031F |
3.3 Sudan Basal Insulin (Long Acting Insulin) Market - Industry Life Cycle |
3.4 Sudan Basal Insulin (Long Acting Insulin) Market - Porter's Five Forces |
3.5 Sudan Basal Insulin (Long Acting Insulin) Market Revenues & Volume Share, By Products, 2021 & 2031F |
4 Sudan Basal Insulin (Long Acting Insulin) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Sudan |
4.2.2 Growing awareness about the benefits of long-acting insulin therapy |
4.2.3 Improving healthcare infrastructure and access to healthcare services in Sudan |
4.3 Market Restraints |
4.3.1 High cost associated with long-acting insulin treatment |
4.3.2 Limited healthcare budget and resources in Sudan |
4.3.3 Challenges in distribution and availability of long-acting insulin products in remote areas |
5 Sudan Basal Insulin (Long Acting Insulin) Market Trends |
6 Sudan Basal Insulin (Long Acting Insulin) Market, By Types |
6.1 Sudan Basal Insulin (Long Acting Insulin) Market, By Products |
6.1.1 Overview and Analysis |
6.1.2 Sudan Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Products, 2021- 2031F |
6.1.3 Sudan Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Lantus, 2021- 2031F |
6.1.4 Sudan Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Levemir, 2021- 2031F |
6.1.5 Sudan Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Tresiba, 2021- 2031F |
6.1.6 Sudan Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Toujeo, 2021- 2031F |
6.1.7 Sudan Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Basaglar, 2021- 2031F |
7 Sudan Basal Insulin (Long Acting Insulin) Market Import-Export Trade Statistics |
7.1 Sudan Basal Insulin (Long Acting Insulin) Market Export to Major Countries |
7.2 Sudan Basal Insulin (Long Acting Insulin) Market Imports from Major Countries |
8 Sudan Basal Insulin (Long Acting Insulin) Market Key Performance Indicators |
8.1 Number of diabetes patients opting for long-acting insulin therapy |
8.2 Rate of adoption of long-acting insulin among healthcare providers in Sudan |
8.3 Patient adherence and compliance to long-acting insulin treatment plan |
8.4 Number of educational campaigns and programs promoting long-acting insulin therapy |
8.5 Availability and accessibility of long-acting insulin in different regions of Sudan |
9 Sudan Basal Insulin (Long Acting Insulin) Market - Opportunity Assessment |
9.1 Sudan Basal Insulin (Long Acting Insulin) Market Opportunity Assessment, By Products, 2021 & 2031F |
10 Sudan Basal Insulin (Long Acting Insulin) Market - Competitive Landscape |
10.1 Sudan Basal Insulin (Long Acting Insulin) Market Revenue Share, By Companies, 2024 |
10.2 Sudan Basal Insulin (Long Acting Insulin) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |